By Kelly C. Simpson, Editor, eBulletin: International Edition
On Wednesday, March 9, 2011 at The Westin Diplomat in Hollywood, Florida, the National Comprehensive Cancer Network® (NCCN®) will convene an NCCN Academy for Excellence & Leadership in Oncology™: School of Pharmaceutical and Biotech Business. This next installment in the successful series of NCCN Academy meetings is timed in conjunction with the start of the NCCN 16th Annual Conference: Clinical Practice Guidelines & Quality Cancer Care™ and will feature three brand new modules.
NCCN Academy will commence promptly at 8:40 AM with opening remarks from Dr. William T. McGivney, Chief Executive Officer of NCCN and Moderator of NCCN Academy. Throughout the day, Dr. McGivney will facilitate panelist introductions and manage the flow of discussions to accommodate the topics of interest to the audience. Each 75-minute session will begin with a foundational conversation among the panelists, prompted by Dr. McGivney who sets the stage for exploration of the hot topics affecting each set of constituents.
NCCN Academy is designed to give pharmaceutical and biotech professionals knowledge learned directly from key stakeholders about the most pressing issues in oncology today, with the goal that those insights will aid them in creating mutually successful working relationships. In keeping with this objective, NCCN Academy is structured for interactivity, allowing substantial time for participant and panelist Q&A. Questions or comments from participants can be asked face-to-face or through anonymous submission on a supplied card for presentation to the appropriate panelist by Dr. McGivney. Addressing the audience inquiries is a main priority at NCCN Academy as this enhances comprehension and value while maintaining a compelling environment that inspires learners.
The March 9 NCCN Academy will give an insider's view into the NCCN Guidelines Panels processes and considerations, including the perspectives of esteemed NCCN Faculty: Dr. Robert W. Carlson, of Stanford Cancer Institute, who serves as the NCCN Breast Cancer Guidelines Panel Chair; Dr. James L. Mohler of Roswell Park Cancer Institute who is the NCCN Prostate Cancer Guidelines Panel Chair; and Dr. Robert J. Morgan of City of Hope Comprehensive Cancer Center, Chair of NCCN's Ovarian Cancer Guidelines Panel. This acclaimed module is the most popular discussion among participants and is included in every NCCN Academy agenda, using a variety of faculty to support the important dialogue.
New modules on March 9 will address employers' challenges and concerns related to paying for drugs and biologics in cancer care, decisions by the Food and Drug Administration and their impact, and the practices and views of Fellows who are today's providers and tomorrow's emerging thought leaders in oncology. You can learn more about the nature of NCCN Academy and view the full March 9 agenda and its impressive faculty roster by visiting nccn.org/academy.
NCCN Academy is also offered in video format for select modules that may be purchased for a 12-month license for companies' internal training purposes. If you are interested in tailoring an NCCN Academy to your companies' needs, please review the list of available custom modules and contact Academy@nccn.org.